COMMUNIQUÉS West-GlobeNewswire

Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics
29/10/2026
U.S. FDA clears IND for Phase 2 study of VT-7208 in chronic spontaneous urticaria; additional Phase 2 studies planned in food allergy and relapsing multiple sclerosis Company expands pipeline through research [...]
MIRA Pharmaceuticals Reports Significant Weight and Fat Reduction With Oral SKNY-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared With Semaglutide
29/10/2026
SKNY-1's Weight Reduction Without Significant Changes in Food Consumption Suggests a Potential Role for Energy Expenditure, Contrasting With Semaglutide's Initial Food-Intake Suppression and Significant Post-Treatment [...]
Intellia Therapeutics Announces Upcoming Lonvoguran Ziclumeran (Lonvo-z) Investor Event and Seven Presentations at ACAAI 2026
29/10/2026
Oral presentations to include four-year follow-up data from patients who received a one-time 50 milligram (mg) dose of lonvo-z; insights on new hereditary angioedema (HAE) treatment goals Poster presentations to include [...]
Vaxart to Host Stockholder Fireside Chat on November 6 at 4:30 p.m. ET
29/10/2026
Company to report third quarter 2026 financial results on November 5 SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range [...]
Collegium Pharmaceutical and Boston Legacy FC Expand Their Partnership Beyond Matchday to Communities Across Massachusetts
29/10/2026
New multi-year partnership combines youth coach training, an annual Sports for All Summit, and sensory inclusion programs to support neurodivergent children and families STOUGHTON, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE [...]
Les Canadien·ne·s font autant confiance à leur dentiste qu’à leur médecin de famille, et 8 sur 10 appuient le Régime canadien de soins dentaires : sondage national de 123Dentiste
29/10/2026
Au moment où la vérificatrice générale publie son rapport, 6 personnes inscrites sur 10 affirment que le Régime canadien de soins dentaires leur a donné accès à des soins autrement hors de portée TORONTO, 29 oct. 2026 ( [...]
Canadians trust their dentist as much as their family doctor, and 8 in 10 support the Canadian Dental Care Plan: 123Dentist national survey
29/10/2026
As the Auditor General releases their report, 6 in 10 Canadian Dental Care Plan enrollees say the program helped them receive care they otherwise could not have. TORONTO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Canadians [...]
Xenon Announces Positive Phase 1 and New Preclinical Data at IASP 2026 Supporting Advancement of XEN1701 and XEN1120 to Phase 2 Proof-of-Concept Studies in Acute Pain
29/10/2026
XEN1701 achieved target profile, including desired Na V 1.7 receptor occupancy in both the peripheral and central nervous system, and was generally well-tolerated with no notable autonomic cardiovascular effects XEN1120 [...]
TOMI Environmental Solutions Secures Three-Phase SteraMist iHP Order from Mexican Pharmaceutical Manufacturer Zeyco
29/10/2026
Multi-line Hybrid System deployment, sourced at INTERPHEX, extends TOMI's integrated automated SteraMist iHP decontamination platform into Latin American pharmaceutical manufacturing FREDERICK, Md., Oct. 29, 2026 (GLOBE [...]
Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026
29/10/2026
Presentation will highlight Virtue SAB’s fundamentally different approach of infusing a large liquid volume of proprietary extended-release SirolimusEFR™ directly into and throughout the vessel wall. Virtue SAB’s [...]
Celcuity Schedules Release of Third Quarter 2026 Financial Results and Webcast/Conference Call
29/10/2026
MINNEAPOLIS, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a commercial-stage biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid [...]
Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026
29/10/2026
THE WOODLANDS, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced the Company will release its third quarter 2026 [...]
Quoin Pharmaceuticals to Announce Corporate Update and Third Quarter 2026 Financial Results on Thursday, November 5, 2026
29/10/2026
ASHBURN, Va., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today [...]
Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural Procedures
29/10/2026
Company Reports 500+ U.S. Leads, Expanding Healthcare Network Relationships, Federal Market Access, International Distribution and 300+ Issued and Pending Patents Worldwide Just 2% Penetration of Estimated U.S. Epidural [...]
Allogene Therapeutics Announces November Investor Events Highlighting Q3 Results and Initial ALLO-329 Autoimmune Clinical Data
29/10/2026
Q3 2026 Financial Results and Business Update Conference Call and Webcast Scheduled for November 5, 2026 at 2:00 p.m. PT/5:00 p.m. ET ALLO-329 Autoimmune Disease Program Webinar Featuring Preliminary Safety and Efficacy [...]
SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08:30 AM ET
29/10/2026
MIAMI, Oct. 29, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and [...]
Codexis to Report Third Quarter 2026 Financial Results on November 12
29/10/2026
REDWOOD CITY, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced that it [...]
Roivant Social Ventures Announced Support of No Patient Left Behind with Six-Figure Organizational Legacy Gift
29/10/2026
NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Today Roivant Social Ventures (RSV) announced it is joining efforts with No Patient Left Behind (NPLB) to improve drug affordability and access while supporting ongoing [...]
Neocis Expands Yomi S® Clearance to Include Pterygoid Implant Placement
29/10/2026
Yomi S receives first and only U.S. FDA clearance for digital guided surgery for pterygoid implants MIAMI, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Neocis ® , the global leader in robotic-assisted dental surgery announced that [...]

Pages